Related Experiment Videos
New interest in an old disease: familial Mediterranean fever
1Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey. sozen@gen.hun.edu.tr
Abstract:
Familial Mediterranean fever (FMF) is characterized by recurrent attacks of fever and serositis. Identifying the mutated gene has shed light on the pathogenesis of the disease. Typical attacks of FMF last 3 to 5 days. Arthritis is present in almost half of all patients and is localized to the ankle, knee or hip. Recently vasculitic features have been increasingly reported in FMF patients, and it may be speculated that vasculitis constitutes a feature of this disease. Genetic analysis is very important to confirm the diagnosis in patients with a European ancestry. However, at present the yield of genetic testing is not satisfactory; new sequencing techniques permitting more rapid screening and definition of all mutations are necessary. Colchicine is the drug of choice. A trial of colchicine may also help in the differential diagnosis with other periodic fever syndromes.
Insights
Familial Mediterranean fever (FMF) involves recurrent fever and inflammation. Genetic testing aids diagnosis, while colchicine remains the primary treatment for this autoinflammatory condition.
Area of Science:
- Rheumatology
- Genetics
- Immunology
Background:
- Familial Mediterranean fever (FMF) is an autoinflammatory disorder.
- Characterized by recurrent episodes of fever and serositis.
- Pathogenesis increasingly understood through gene identification.
Purpose of the Study:
- To review the clinical and genetic aspects of FMF.
- To highlight the role of genetic analysis in diagnosis.
- To discuss current and future therapeutic strategies.
Main Methods:
- Literature review of FMF studies.
- Analysis of genetic testing yields and limitations.
- Evaluation of colchicine's efficacy and diagnostic utility.
Main Results:
- FMF presents with fever, serositis, and arthritis; vasculitic features are emerging.
- Genetic testing is crucial for European ancestry patients but requires improvement.
- Colchicine is the established treatment and aids in differentiating FMF from other periodic fevers.
Conclusions:
- Understanding FMF genetics has advanced disease insight.
- Improved genetic sequencing techniques are needed for better mutation detection.
- Colchicine remains the cornerstone of FMF management and differential diagnosis.